Homozygous C2 deficiency with fulminant lupus erythematosus. severe nephritis via the alternative complement pathway (Q40855806)

reason for preferred rank

24 September 2017

title

Homozygous C2 deficiency with fulminant lupus erythematosus. severe nephritis via the alternative complement pathway (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Homozygous C2 deficiency with fulminant lupus erythematosus: severe nephritis via the alternative complement pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

1 reference

A. Gewurz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

T. F. Lint

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

J. L. Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

H. Zeitz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

H. Gewurz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A341897

31 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=341897

31 March 2023

publication date

1 January 1978

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780210106

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780210106

31 March 2023

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

published in

Arthritis & Rheumatology

1 reference

24 September 2017

Arthritis and Rheumatism

21

1

28–36

January 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=341897

31 March 2023

volume

21

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

28-36

1 reference

Inherited Complement Deficiencies and Systemic Lupus Erythematosus: an Immunogenetic Puzzle

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FART.1780210106

Inherited C2 deficiency and systemic lupus erythematosus: studies on a family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780210106

Inherited deficiency of the second component of complement. Rheumatic disease associations

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Transplantation reviews

2

32

43

Jersild

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Hereditary C2 deficiency. Association with skin lesions resembling the discoid lesion of systemic lupus erythematosus

31 March 2023

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

The complement system in chronic glomerulonephritis: Three newly associated aberrations

31 March 2023

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

C2 deficiency. Development of lupus erythematosus

31 March 2023

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic Linkage Between the HL-A System and a Deficit of the Second Component (C2) of Complement

31 March 2023

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic deficiency of the second component of complement (C2) associated with systemic lupus erythematosus. Relation of the complement abnormality and disease manifestations

31 March 2023

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Deficiency of the sixth component of complement in rabbits with an inherited complement defect

31 March 2023

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis

31 March 2023

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

17

24

543a

Lint

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Federation Proceedings

23

34

983

Polhill

1975

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function

31 March 2023

24

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Federation Proceedings

27

35

493

Behrends

1976

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.

31 March 2023

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Hereditary C2 deficiency: Genetic studies and association with the HL-A system

31 March 2023

32

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families

31 March 2023

33

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and deficiency of the second component of complement

31 March 2023

36

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Genetic loci of components of the classical and alternate pathway of complement activation: A new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man

31 March 2023

37

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Linkage of HL-A and GBG

38

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide

31 March 2023

40

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases

31 March 2023

44

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Biosynthetic Defect in Monocytes from Human Beings with Genetic Deficiency of the Second Component of Complement

31 March 2023

45

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia

31 March 2023

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

31 March 2023

47

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation

31 March 2023

48

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis

31 March 2023

49

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

31 March 2023

50

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Correlation of a Precipitin Reaction to an RNA-Protein Antigen and a Low Prevalence of Nephritis in Patients with Systemic Lupus Erythematosus

31 March 2023

51

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Characteristics of patients with serum antibodies to extractable nuclear antigens

31 March 2023

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement

31 March 2023

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway

31 March 2023

54

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation

31 March 2023

55

1 reference

https://api.crossref.org/works/10.1002/ART.1780210106

31 March 2023

Identifiers

1 reference

24 September 2017

1 reference